<?xml version="1.0" ?>
<TimeML xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://timeml.org/timeMLdocs/TimeML_1.2.1.xsd">

<DOCID>695195532349</DOCID>

<DCT><TIMEX3 tid="t0" type="DATE" value="20170129" temporalFunction="false" functionInDocument="CREATION_TIME">January 29, 2017</TIMEX3></DCT>

<TITLE>Immunotolerant indoleamine-2,3-dioxygenase increases in condyloma acuminata</TITLE>


<TEXT>
Abstract  Background  
The tryptophan-depleting enzyme indoleamine-2,3-dioxygenase (IDO) is <EVENT eid="e1" class="STATE">critical</EVENT> for the <EVENT eid="e2" class="OCCURRENCE">regulation</EVENT> of immune tolerance and <EVENT eid="e3" class="I_STATE">plays</EVENT> an important role in immune-associated skin diseases. 
 Objectives  
To <EVENT eid="e4" class="OCCURRENCE">analyze</EVENT> the level of IDO in condyloma acuminata (CA) and its role in this condition. 
 Methods  
IDO expression was <EVENT eid="e5" class="OCCURRENCE">assessed</EVENT> in the skin and peripheral blood of healthy subjects and patients with CA. To <EVENT eid="e6" class="OCCURRENCE">assess</EVENT> the role of skin IDO in immunity, the ability of isolated epidermal cells to metabolize tryptophan and the influence on polyclonal T cell mitogen (PHA)-<EVENT eid="e7" class="OCCURRENCE">stimulated</EVENT> T cell proliferation were <EVENT eid="e8" class="OCCURRENCE">explored</EVENT>. 
 Results  
IDO median fluorescence intensities (MFIs) in peripheral blood mononuclear cells (PBMCs) from CA patients were similar to those from healthy controls. Immunohistochemistry <EVENT eid="e9" class="REPORTING">showed</EVENT> that IDO(+) cells were rare in normal skin and the control skin of CA patients but were greatly <EVENT eid="e10" class="OCCURRENCE">accumulated</EVENT> in wart tissue. Most fluorescence signals of IDO(+) cells were not <EVENT eid="e11" class="OCCURRENCE">overlapping</EVENT> with those of CD1a(+) Langerhans cells (LCs). HPV DNA probe in situ hybridization <EVENT eid="e12" class="OCCURRENCE">showed</EVENT> a large number of IDO(+) cells in the HPV(-) site. Keratinocytes (KCs) in the skin of healthy subjects and the circumcised skin of CA patients could minimally <EVENT eid="e13" class="OCCURRENCE">transform</EVENT> tryptophan into kynurenine, but IDO-competent epidermal cells from warts could <EVENT eid="e14" class="ASPECTUAL">transform</EVENT> tryptophan. In addition, these IDO-competent epidermal cells could <EVENT eid="e15" class="OCCURRENCE">inhibit</EVENT> PHA-stimulated T cell proliferation. The <EVENT eid="e16" class="OCCURRENCE">addition</EVENT> of an IDO inhibitor 1-MT <EVENT eid="e17" class="I_ACTION">restored</EVENT> the inhibited T cell proliferation. 
 Conclusion  
Abnormally localized high IDO expression might be <EVENT eid="e18" class="OCCURRENCE">involved</EVENT> in the formation of a local immune tolerant microenvironment. 
 
This <EVENT eid="e19" class="OCCURRENCE">article</EVENT> is <EVENT eid="e20" class="OCCURRENCE">protected</EVENT> by copyright. All rights <EVENT eid="e21" class="REPORTING">reserved</EVENT>.
</TEXT>


<MAKEINSTANCE eiid="ie19" eventID="e19" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie18" eventID="e18" pos="ADJECTIVE" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie11" eventID="e11" pos="VERB" tense="PAST" aspect="PROGRESSIVE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie10" eventID="e10" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie13" eventID="e13" pos="UNKNOWN" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie12" eventID="e12" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie15" eventID="e15" pos="VERB" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie14" eventID="e14" pos="VERB" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie17" eventID="e17" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie16" eventID="e16" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie9" eventID="e9" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie8" eventID="e8" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie5" eventID="e5" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie4" eventID="e4" pos="VERB" tense="FUTURE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie7" eventID="e7" pos="VERB" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie6" eventID="e6" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie1" eventID="e1" pos="ADJECTIVE" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie3" eventID="e3" pos="UNKNOWN" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie2" eventID="e2" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie20" eventID="e20" pos="UNKNOWN" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie21" eventID="e21" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />

<TLINK lid="TL1" eventInstanceID="ie14" relatedToEventInstance="ie13" relType="AFTER" />
<TLINK lid="TL0" eventInstanceID="ie13" relatedToEventInstance="ie14" relType="AFTER" />
<TLINK lid="TL3" eventInstanceID="ie16" relatedToEventInstance="ie17" relType="AFTER" />
<TLINK lid="TL2" eventInstanceID="ie17" relatedToEventInstance="ie16" relType="AFTER" />
</TimeML>
